Background of the LECMC

Experimental Cancer Medicine Centres are a joint initiative between Cancer Research UK and the departments of health in England, Scotland and Wales. Its funding replaces NTRAC support and provides infrastructure support for staff and running costs to underpin early phase trials and translational research.

The Liverpool Experimental Cancer Medicine Centre has been awarded to the University of Liverpool (School of Cancer Studies and Pharmacology) and the NHS partners of the Royal Liverpool University Hospital and Clatterbridge Centre for Oncology and will be managed by the Liverpool Cancer Trials Unit.